Significance of serum human hepatocyte growth factor levels in patients with hepatic failure.
Serum human hepatocyte growth factor levels were measured using a newly developed enzyme-linked immunosorbent assay kit in patients with liver diseases. Serum human hepatocyte growth factor levels were increased in correlation with derangements of prothrombin time, total bilirubin and other parameters reflecting hepatocellular dysfunction in 112 patients with chronic liver disease. The levels were positively correlated with serum AST and ALT levels in 59 of these patients whose prothrombin times were within the normal range. Abnormally increased serum human hepatocyte growth factor levels were found in 100% of the determinations in 16 patients with fulminant hepatic failure and in 80% of the determinations in 16 patients with chronic hepatic failure. The levels greater than 1 ng/ml, however, were found in 94% of determinations in the former group, but only in 16% of the determinations in the latter group. This difference was seen irrespective of prothrombin time or hepatic coma grades. In patients with fulminant hepatic failure serum human hepatocyte growth factor levels were increased immediately after plasma exchange using heparin as the anticoagulant in 71% of the determinations. This increase disappeared 12 hr after discontinuation of plasma exchange. In 17 of 39 patients with chronic renal failure who had no liver disease, serum human hepatocyte growth factor levels were abnormally increased before hemodialysis using heparin, and the levels were elevated immediately after hemodialysis in all the patients. The increase of serum human hepatocyte growth factor levels in hepatic failure may be the result of hepatocellular dysfunction and necrosis.(ABSTRACT TRUNCATED AT 250 WORDS)
Tomiya
T
T
First Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.
Nagoshi
S
S
Fujiwara
K
K
D002908:Chronic Disease; D005260:Female; D006133:Growth Substances / Q000097:blood*; D017228:Hepatocyte Growth Factor; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood; D008107:Liver Diseases / Q000097:blood* / Q000628:therapy; D008115:Liver Regeneration; D008297:Male; D008875:Middle Aged; D010951:Plasma Exchange
D006133:Growth Substances; D017228:Hepatocyte Growth Factor